微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 7.33% | -14.77% | 79.66% | 17/157 | 1.37% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 4.08% | -14.11% | -71.17% | 19/157 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 14.15% | 2.98% | 14.67% | 10/157 | -4.46% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 12.34% | -0.4% | 43.49% | 15/157 | 1.31% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 8.6% | -1.04% | 81.05% | 16/157 | 0.3% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 4.75% | 15.57% | -65.43% | 14/157 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 13.74% | 17.44% | 10.9% | 16/157 | -9.62% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 12.39% | 14.72% | 42.58% | 15/157 | 4.28% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 8.69% | 24.5% | 111.44% | 14/157 | 2.69% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 4.11% | 15.77% | -64.87% | 12/157 | 2.35% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 11.7% | 6.85% | 8.33% | 22/157 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 10.8% | 10.88% | 54.73% | 21/157 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 6.98% | 2.2% | 96.62% | 19/157 | 1.48% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.55% | 7.58% | -67.58% | 25/157 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 10.95% | 19.93% | 12.42% | 41/157 | 0.79% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 9.74% | 5.18% | 42.61% | 30/157 | 2.86% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 6.83% | 16.55% | 106.97% | 26/157 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.3% | 8.91% | -63.86% | 30/157 | 1.59% | ST人福 | 6.82% | 行业排名> |
| 2021-12-31 | 9.13% | -15.54% | -1.4% | 45/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 9.26% | -5.61% | 58.02% | 38/157 | 4.46% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.86% | -1.84% | 93.4% | 40/157 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.03% | -3.81% | -71.97% | 42/157 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 10.81% | -11.18% | 10.19% | 46/157 | 3.8% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 9.81% | -12.72% | 64.32% | 37/157 | 3.13% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.97% | -16.03% | 89.52% | 43/157 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 3.15% | -23.36% | -74.12% | 31/157 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 12.17% | 1.76% | 8.27% | 39/157 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 11.24% | 2.27% | 58.09% | 26/157 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 7.11% | -1.8% | 72.99% | 28/157 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 4.11% | 4.05% | -65.64% | 18/157 | 2.45% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 11.96% | 3.55% | 8.83% | 40/157 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 10.99% | 6.7% | 51.8% | 19/157 | 7.21% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 7.24% | -0.14% | 83.29% | 21/157 | 4.63% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.95% | 14.49% | -65.8% | 16/157 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 11.55% | 12.03% | 12.14% | 41/157 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 10.3% | 9.69% | 42.07% | 24/157 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 7.25% | 13.28% | 110.14% | 26/157 | 5.56% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.45% | 17.35% | -66.54% | 19/157 | 2.1% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 10.31% | 47.92% | 9.8% | 53/157 | 6.05% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 9.39% | 5.98% | 46.72% | 27/157 | 5.64% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 6.4% | 20.3% | 117.69% | 31/157 | 3.52% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 2.94% | -8.13% | -57.82% | 29/157 | 2.69% | 贝达药业 | 16.78% | 行业排名> |